Kessler Foundation studies effects of Tysabri on cognitive fatigue in multiple sclerosis

(Kessler Foundation) The majority of persons with MS have cognitive fatigue, which can adversely affect their ability to perform everyday life activities. Although 40% consider cognitive fatigue their most troubling symptom, there are few treatment options. None of the pharmacological interventions used to slow progression of physical disability are indicated for treating cognitive fatigue. This is the first study to explore whether treatment with Tysabri may alleviate cognitive fatigue in individuals with MS.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news